Primary optic nerve tumours

Current Opinion in Neurology

Volumn 22, Issue 1, 2009, Pages 11-18

  Wilhelm, Helmut ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Low grade glioma; Optic glioma; Optic nerve meningioma; Pilocytic astrocytoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; IRINOTECAN; MIFEPRISTONE; MITOMYCIN C; SOMATOSTATIN DERIVATIVE; TEMOZOLOMIDE; VASCULOTROPIN; VINCRISTINE;

ASTROCYTOMA; CANCER INVASION; CANCER SURVIVAL; CHILDHOOD; CHORISTOMA; CLINICAL FEATURE; COMPUTER ASSISTED RADIOTHERAPY; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; EVOKED VISUAL RESPONSE; HEMANGIOBLASTOMA; HEMANGIOPERICYTOMA; HUMAN; LYMPHOMA; MALIGNANT TRANSFORMATION; MENINGIOMA; MOYAMOYA DISEASE; NEUROFIBROMATOSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; OPTIC NERVE MENINGIOMA; OPTIC NERVE TUMOR; OPTIC NEURITIS; PRIMARY TUMOR; PROGNOSIS; RADIATION INJURY; RADIOSURGERY; REVIEW; STEREOTACTIC TREATMENT; TREATMENT PLANNING; TUMOR DIAGNOSIS; UNSPECIFIED SIDE EFFECT;

CHILD; COMBINED MODALITY THERAPY; DRUG THERAPY; GLIOMA; HUMANS; MENINGIOMA; NEUROFIBROMATOSIS 1; NEUROSURGICAL PROCEDURES; OPTIC NERVE NEOPLASMS; PROGNOSIS; RADIOTHERAPY;

EID: 60449085555     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32831fd9f5     Document Type: Review

References (131)

1. Kortmann R-D, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy. Strahlenther Onkol 2003; 179:509-520.
2. Dutton JJ. Optic nerve gliomas and meningiomas. Neurol Clin 1991; 9:163-177.
3. Sylvester CL, Drohan LA, Sergott RC. Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. Curr Opin Ophthalmol 2006; 17:7-11.
4. Lama G, Esposito Salsano M, Grassia C, et al. Neurofibromatosis type 1 and optic pathway glioma, a long-term follow-up. Minerva Pediatr 2007; 59:13-21. Data on long-term follow-up, but with a small number of patients.
5. Serova NK, Lazareva LA, Ozerova VI, et al. Specific features of manifestation of anterior optic tract gliomas in patients with type 1 neurofibromatosis: ophthalmological and neurovisualizational aspects. Vestn Oftalmol 2006; 122:36-39.
6. Burnstine MA, Levin LA, Louis DN, et al. Nucleolar organizer regions in optic gliomas. Brain 1993; 116 (Pt 6):1465-1476.
7. Leonard JR, Perry A, Rubin JB, et al. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology 2006; 67:1509-1512.
8. Tumialan LM, Dhall SS, Biousse V, Newman NJ. Optic nerve glioma and optic neuritis mimicking one another: case report. Neurosurgery 2005; 57:E190; discussion E190.
9. Balcer LJ, Liu GT, Heller G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 2001; 131:442-445.
10. Hoyt WF, Baghdassarian SA. Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol 1969; 53:793-798.
11. Imes RK, Hoyt WF. Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study. Br J Ophthalmol 1986; 70:179-182.
12. Dalla Via P, Opocher E, Pinello ML, et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol 2007; 9:430-437.
13. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007; 61:189-198. Review paper with clear recommendations for neurofibromatosis 1 patients on the basis of current knowledge.
14. Hwang J-M, Cheon J-E, Wang K-C. Visual prognosis of optic glioma. Childs Nerv Syst 2008; 24:693-698.
15. Parsa CF, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 2001; 119:516-529.
16. Piccirilli M, Lenzi J, Delfinis C, et al. Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature. Childs Nerv Syst 2006; 22:1332-1337.
17. Trisciuzzi MTS, Riccardi R, Piccardi M, et al. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 2004; 115:217-226.
18. Wolsey DH, Larson SA, Creel D, Hoffman R. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS 2006; 10:307-311.
19. Moradi P, Robson AG, Rose GE, Holder GE. Electrophysiological monitoring in a patient with an optic nerve glioma. Doc Ophthalmol 2008; 117:171-174.
20. Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 2006; 42:1807-1816.
21. Mulhern RK, Merchant TE, Gajjar A, et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5:399-408.
22. Packer RJ, Gurney JG, Punyko JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003; 21:3255-3261.
23. Anderson NE. Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol 2003; 16:677-683.
24. Lau N, Feldkamp MM, Roncari L, et al. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 2000; 59:759-767.
25. Shamji MF, Benoit BG. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Neurosurg Focus 2007; 23:E3.
26. Sharif S, Ferner R, Birch JM, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 2006; 24:2570-2575.
27. Parsa CF, Givrad S. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas. BrJ Ophthalmol 2008; 92:40-46. This metaanalysis gave two results: first, spontaneous malignant transformation of low-grade gliomas is very rare; second, if this happens the patient had been irradiated early in life.
28. Beyer RA, Paden P, Sobel DF, Flynn FG. Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology 1986; 36:1173-1178.
29. Kestle JR, Hoffman HJ, Mock AR. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 1993; 79:32-35.
30. Maruyama K, Mishima K, Saito N, et al. Radiation-induced aneurysm and moyamoya vessels presenting with subarachnoid haemorrhage. Acta Neurochir (Wien) 2000; 142:139-143.
31. Serdaroglu A, Simsek F, Gucuyener K, et al. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report. J Child Neurol 2000; 15:765-767.
32. Desai SS, Paulino AC, Mai WY, Teh BS. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys 2006; 65:1222-1227.
33. Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007; 68:932-938. Retrospective study helpful to assess the risk of moyamoya after cerebral radiotherapy. Three and a half per cent of 345 patients suffered from this complication. Neurofibromatosis 1 triples the risk.
34. Kortmann R-D, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 2003; 179:585-597.
35. Fouladi M, Wallace D, Langsten JW, et al. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer 2003; 97:1084-1092.
36. Combs SE, Schulz-Ertner D, Moschos D, et al. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 2005; 62:814-819.
37. Saran FH, Baumert BG, Khoo VS, et al. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int J Radiat Oncol Biol Phys 2002; 53:43-51.
38. Debus J, Kocagoncu KO, Hoss A, et al. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys 1999; 44:243-248.
39. Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr Blood Cancer 2006; 46:586-596.
40. Suarez JC, Viano JC, Zunino S, et al. Management of child optic pathway gliomas: new therapeutical option. Childs Nerv Syst 2006; 22:679-684.
41. Herrera EJ, Viano JC, Gomez JM, et al. Interstitial stereotactic radiosurgery of pilocytic astrocytomas in paediatric patients. Acta Neurochir (Wien) 2007; 149:887-896; discussion 896. Clinical study showing that interstitial radiotherapy gives good results in optic glioma, but only 12 patients were treated. It is, therefore, not possible to determine whether this is superior to multifractioned stereotactic teletherapy; however, the value of this additional option is underlined.
42. Grill J, Bhangoo R. Recent development in chemotherapy of paediatric brain tumours. Curr Opin Oncol 2007; 19:612-615. Overview on current options in chemotherapy of paediatric brain tumours addressing also low-grade glioma.
43. Silva MM, Goldman S, Keating G, et al. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg 2000; 33:151-158.
44. Mahoney DHJ, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol 2000; 2:213-220.
45. Mantadakis E, Raissaki M, Danilatou V, et al. Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review. J Neurooncol 2004; 67:95-100.
46. Moghrabi A, Friedman HS, Ashley DM, et al. Phase II study of carboplatin (CBDCA) in progressive low-grade gliomas. Neurosurg Focus 1998; 4:e3.
47. Gnekow AK, Kortmann R-D, Pietsch T, Emser A. Low grade chiasmatic-hypothalamic glioma: carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy - report from the multicenter treatment study for children and adolescents with a low grade glioma - HIT-LGG 1996 - of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr 2004; 216:331-342.
48. Gururangan S, Fisher MJ, Alien JC, et al. Temozolomide in children with progressive low-grade glioma. Neuro Oncol 2007; 9:161-168.
49. Zeid JL, Charrow J, Sandu M, et al. Orbital optic nerve gliomas in children with neurofibromatosis type 1. J AAPOS 2006; 10:534-539.
50. Pytel P. Spectrum of pediatric gliomas: implications for the development of future therapies. Expert Rev Anticancer Ther 2007; 7:S51-S60.
51. Tong Z, Wanibuchi M, Uede T, et al. Significant improvement of visual functions after removal of an intracranial giant optic nerve glioma revealing exophytic growth: case report. Neurosurgery 2006; 58:E792; discussion E792.
52. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 2003; 17:327-335.
53. Kaufman LM, Doroftei O. Optic glioma warranting treatment in children. Eye 2006; 20:1149-1164.
54. Massimi L, Tufo T, Di Rocco C. Management of optic-hypothalamic gliomas in children: still a challenging problem. Expert Rev Anticancer Ther 2007; 7:1591-1610. Overview from a pediatric neurosurgical point of view.
55. Lee AG. Neuroophthalmological management of optic pathway gliomas. Neurosurg Focus 2007; 23:E1. Overview from an ophthalmological point of view.
56. Perry A, Scheithauer BW, Stafford SL, et al. 'Malignancy' in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85:2046-2056.
57. Amoli FA, Mehrabani PM, Tari AS. Aggressive orbital optic nerve meningioma with benign microscopic features: a case report. Orbit 2007; 26:271-274. This report illustrates well the discrepancy between histology and clinical beha-viour seen in optic nerve meningioma.
58. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol 2005; 49:49-55.
59. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture. Part 1. Ophthalmology 2004; 111:997-1008.
60. Bosch MM, Boltshauser E, Harpes P, Landau K. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 2006; 141:1068-1077.
61. Bosch MM, Wichmann WW, Boltshauser E, Landau K. Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol 2006; 124:379-385.
62. Turbin RE, Thompson CR, Kennerdell JS, et al. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 2002; 109:899-900; discussion 890-899.
63. Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus 2007; 23:E4.
64. Roser F, Nakamura M, Martini-Thomas R, et al. The role of surgery in meningiomas involving the optic nerve sheath. Clin Neurol Neurosurg 2006; 108:470-476.
65. Chipczynska B, Gralek M, Trzebicka A, et al. Bilateral optic nerve sheath meningioma (ONSM)-diagnostic and therapeutic problems [in Polish). Klin Oczna 2006; 108:202-205.
66. Claus EB, Black PM, Bondy ML, et al. Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 2007; 110:471-476. Overview on several studies giving evidence on hormone replacement therapy elevating the risk of developing meningioma. The authors emphasize that data are insufficient for a clear recommendation.
67. Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 2008; 26:279-282. This new retrospective study on 1260 women with meningioma indicates clearly that hormone replacement therapy increases the risk of developing meningioma.
68. Berete R, Vignal-Clermont C, Boissonnet H, et al. Optic nerve sheath meningioma: diagnosis and new treatment options, a case study of monocular blindness during pregnancy. J Fr Ophtalmol 2006; 29:426-431.
69. Benichou C, Sahel J, Maitrot D, et al. Bilateral meningioma of the optic nerve. Discussion apropos of a case [in French]. J Fr Ophtalmol 1987; 10:783-787.
70. Cunliffe IA, Moffat DA, Hardy DG, Moore AT. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2. Br J Ophthalmol 1992; 76:310-312.
71. Hart WM Jr, Burde RM, Klingele TG, Perlmutter JC. Bilateral optic nerve sheath meningiomas. Arch Ophthalmol 1980; 98:149-151.
72. Liano H, Garcia-Alix C, Lousa M, et al. Bilateral optic nerve meningioma. Case report. Eur Neurol 1982; 21:102-106.
73. Rohr J, Gauthier G. Bilateral meningiomas of the optic nerves associated with partial unilateral Duane's syndrome [in French]. Rev Neurol (Paris) 1984; 140:637-641.
74. Sawaya RA, Sidani C, Farah N, Hourani-Risk R. Presumed bilateral optic nerve sheath meningiomas presenting as optic neuritis. J Neuroophthalmol 2008; 28:55-57. Interesting case report illustrating diagnostic difficulties.
75. Lewis T, Kingsley D, Moseley I. Do bilateral optic nerve sheath meningiomas exist? Br J Neurosurg 1991; 5:13-18.
76. Turbin RE, Pokorny K. Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control 2004; 11:334-341.
77. Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningio-ma. Br J Ophthalmol 1989; 73:960-966.
78. Saeed P, Rootman J, Nugent RA, et al. Optic nerve sheath meningiomas. Ophthalmology 2003; 110:2019-2030.
79. Sibony PA, Krauss HR, Kennerdell JS, et al. Optic nerve sheath meningiomas. Clinical manifestations. Ophthalmology 1984; 91:1313-1326.
80. Carrasco JR, Penne RB. Optic nerve sheath meningiomas and advanced treatment options. Curr Opin Ophthalmol 2004; 15:406-410.
81. de Alba Campomanes AG, Larson DA, Horton JC. Immediate shrinkage of optociliary shunt vessels after fractionated external beam radiation for meningioma of the optic nerve sheath. AJNR Am J Neuroradiol 2008; 29:1360-1362.
82. Ban Y, Ohde H, Sugisaka E, Shinoda K. Enlargement of optic nerve resembling orbital mass in case of optic neuritis. Graefes Arch Clin Exp Ophthalmol 2007; 245:911-913. One more caveat to relying only on imaging in diagnosis of optic nerve meningioma.
83. Dutton JJ, Andersen RL. Idiopathic inflammatory perioptic neuritis simulating optic nerve sheath meningioma. Am J Ophthalmol 1985; 100:424-430.
84. Zhang TL, Shao SF, Zhang T, et al. Idiopathic inflammation of optic nerve simulating optic nerve sheath meningioma. Chin Med J (Engl) 1987; 100:541-542.
85. Ugurlu S, Bartley GB. Evolution of an orbital apex tumor over a decade. Ophthal Plast Reconstr Surg 2004; 20:75-77.
86. Selva D, Rootman J, Crompton J. Orbital lymphoma mimicking optic nerve meningioma. Orbit 2004; 23:115-120.
87. Lessell S, Kim JW, Hatton MP, et al. Clinical without histopathological manifestations of inflammation in a patient with primary intraorbital optic nerve sheath meningioma. J Neuroophthalmol 2007; 27:104-106. Highly interesting case of co-existing obvious autoimmune optic neuropathy and biopsy proven optic nerve meningioma.
88. Kennerdell JS, Maroon JC, Malton M, Warren FA. The management of optic nerve sheath meningiomas. Am J Ophthalmol 1988; 106:450-457.
89. Miller NR. New concepts in the diagnosis and management of optic nerve sheath meningioma. J Neuroophthalmol 2006; 26:200-208.
90. Pitz S, Becker G, Schiefer U, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol 2002; 86:1265-1268.
91. Landert M, Baumert BG, Bosch MM, et al. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J Neuroophthalmol 2005; 25:86-91.
92. Litre CF, Noudel R, Colin P, et al. Fractionated stereotactic radiotherapy for optic nerve sheath meningioma: eight cases [in French]. Neurochirurgie 2007; 53:333-338.
93. Llorente-Gonzalez S, Arbizu-Duralde A, Pastora-Salvador N. Fractionated stereotactic radiotherapy in optic nerve sheath meningioma [in Spanish]. Arch Soc Esp Oftalmol 2008; 83:441-444.
94. Richards JC, Roden D, Harper CS. Management of sight-threatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy. Clin Experiment Ophthalmol 2005; 33:137-141.
95. Sitathanee C, Dhanachai M, Poonyathalang A, et al. Stereotactic radiation therapy for optic nerve sheath meningioma; an experience at Ramathibodi Hospital. J Med Assoc Thai 2006; 89:1665-1669.
96. Kerty E. Optic nerve sheath meningioma-from expectation to active treatment [in Norwegian). Tidsskr Nor Laegeforen 2005; 125:429-430.
97. Mouton S, Tilikete C, Bernard M, et al. Optic nerve sheath meningioma. Experience in Lyon with twenty patients [in French]. Rev Neurol (Paris) 2007; 163:549-559.
98. Berman D, Miller NR. New concepts in the management of optic nerve sheath meningiomas. Ann Acad Med Singapore 2006; 35:168-174.
99. Jeremic B, Pitz S. Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice. Cancer 2007; 110:714-722.
100. Moster ML. Detection and treatment of optic nerve sheath meningioma. Curr Neurol Neurosci Rep 2005; 5:367-375.
101. Radhakrishnan S, Lee MS. Optic nerve sheath meningiomas. Curr Treat Options Neurol 2005; 7:51-55.
102. Vagefi MR, Larson DA, Horton JC. Optic nerve sheath meningioma: visual improvement during radiation treatment. Am J Ophthalmol 2006; 142:343-344.
103. Finger PT. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol 2007; 143:335-338.
104. Krishnan R, Kumar I, Kyle G, John Husband D. Radiation retinopathy after fractionated stereotactic conformal radiotherapy for primary intraorbital optic nerve sheath meningioma. J Neuroophthalmol 2007; 27:143-144.
105. Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci 2008; 15:95-100. Review describing the risk factors and time course of radiation-induced optic neuropathy. There is still no effective treatment.
106. Bhandare N, Monroe AT, Morris CG, et al. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 2005; 62:1070-1077.
107. Kollova A, Liscak R, Novotny J Jr, et al. Gamma knife surgery for benign meningioma. J Neurosurg 2007; 107:325-336.
108. Adler JR Jr, Gibbs IC, Puataweepong P, Chang SD. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 2006; 59:244-254; discussion 244-254.
109. Romanelli P, Wowra B, Muacevic A. Multisession CyberKnife radiosurgery for optic nerve sheath meningiomas. Neurosurg Focus 2007; 23:E11.
110. Jeremic B, Pitz S, editors. Primary optic nerve sheath meningioma. Springer: Heidelberg; 2008 Comprehensive monograph within the Medical Radiology - Radiation Oncology series, covering all aspects of optic nerve sheath menigiomas including clinical and genetic aspects. Different radiotherapy approaches are described in detail and data about outcome and toxicity are provided.
111. Henze M, Schuhmacher J, Hipp P, et al. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med 2001; 42:1053-1056.
112. Milker-Zabel S, Zabel-du Bois A, Henze M, et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys 2006; 65:222-227.
113. Ringel F, Cedzich C, Schramm J. Microsurgical technique and results of a series of 63 spheno-orbital meningiomas. Neurosurgery 2007; 60:214-221; discussion 221-212.
114. Schick U, Dott U, Hassler W. Surgical management of meningiomas involving the optic nerve sheath. J Neurosurg 2004; 101:951-959.
115. Turbin RE, Wladis EJ, Frohman LP, et al. Role for surgery as adjuvant therapy in optic nerve sheath meningioma. Ophthal Plast Reconstr Surg 2006; 22:278-282.
116. Dhoot DS, Shults WT, Ng JD. Successful use of mitomycin C to prevent recurrence of the cystic component of an optic nerve sheath meningioma. Ophthal Plast Reconstr Surg 2008; 24:235-236.
117. Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage • therapy with long-acting somatostatin analogue. Neurology 2007; 69:969-973. A possible treatment option if radiotherapy fails is presented, but no optic nerve meningioma was included in this study.
118. Grunberg SM, Weiss MH, Russell CA, et al. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest 2006; 24:727-733.
119. Chamberlain MC, Tsao-Wei DD, Groshen S. Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol 2006; 78:271-276.
120. Hartel PH, Rosen C, Larzo C, Nestor S. Malignant optic nerve glioma (glioblastoma multiforme): a case report and literature review. W V Med J 2006; 102:29-31.
121. Romano LM, Gaspari M, Guagnini M. Bilateral malignant astrocytoma of the optic nerve in the adult [in Spanish], Neurologia 2007; 22:389-390.
122. Danesh-Meyer HV, Savino PJ, Bilyk JR, Sergott RC. Aggressive glioma of adulthood simulating ischemic optic neuropathy. Arch Ophthalmol 2005; 123:694-700.
123. Hoyama E, Cruz AA, Colli BO, et al. Isolated low grade pilocytic astrocytoma of the optic nerve in the elderly: case report. Arq Bras Oftalmol 2008; 71:97-100. One more case demonstrating that age of onset rather than histology predicts behaviour of an optic glioma.
124. Miyamoto J, Sasajima H, Owada K, Mineura K. Surgical decision for adult optic glioma based on [18F]fluorodeoxyglucose positron emission tomography study. Neurol Med Chir (Tokyo) 2006; 46:500-503.
125. Behbehani RS, Vacarezza N, Sergott RC, et al. Isolated optic nerve lymphoma diagnosed by optic nerve biopsy. Am J Ophthalmol 2005; 139:1128-1130.
126. Millar MJ, Tumuluri K, Murali R, et al. Bilateral primary optic nerve lymphoma. Ophthal Plast Reconstr Surg 2008; 24:71-73.
127. Mateo J, Abarzuza R, Nunez E, Cristobal JA. Bilateral optic nerve infiltration in acute lymphoblastic leukemia in remission. Arch Soc Esp Oftalmol 2007; 82:167-170.
128. Higashida T, Sakata K, Kanno H, et al. Hemangioblastoma of the optic nerve-case report. Neurol Med Chir (Tokyo) 2007; 47:215-218.
129. Schwent BJ, Wojno TH, Grossniklaus HE. Hemangiopericytoma of the optic nerve sheath. Am J Ophthalmol 2007; 143:904-906.
130. Spencer A, Lee J, Prayson RA. Optic nerve choristoma. Ann Diagn Pathol 2005; 9:93-95.
131. Vajramani GV, Dambatta S, Walker M, Grundy PL. Multiple gangliogliomas of the optic pathway. Br J Neurosurg 2006; 20:428-430.